Taylor & Francis

In this interview Roshaine Wijayatunga (Senior Editor: Oncology) speaks with David Jayne about colorectal surgery in regards to the development, application and evaluation of new surgical technologies.

In this interview Roshaine Wijayatunga (Senior Editor: Oncology) speaks with Matthew Ellis at the 2017 NCRI Cancer Conference 5–8 Nov 2017 about the future of proteomics and breast cancer research.

In this interview Roshaine Wijayatunga (Senior Editor: Oncology) speaks with Michael Douek at the 2017 NCRI Cancer Conference 5–8 Nov 2017 about novel techniques for breast surgery and reconstruction.

In this World AIDS Day interview we speak to Richard Koup, who was recently an author on a study reporting a trispecific antibody able to target 99% of HIV strains.

www.id-hub.com

One of the major themes from this year’s SfN Neuroscience meeting (Washington DC, USA, 11–15 November 2017) was developments in neuromodulation techniques, including deep brain stimulation (DBS) and transcranial magnetic stimulation (TMS). One study highlighted by the society came from Nicole Swann (University of California, San Francisco, LA, USA) and colleagues, who presented evidence that a novel implantable device can both provide DBS and record activity at the brain surface, providing feedback and causing the device to moderate stimulation level according to the patient’s levels of dyskinesia.

Whilst at the conference, Lauren Pulling (Editor) sat down with Nicole to hear more about the study and its implications for patients and future research – you can listen to the podcast here. Plus, you can find our round-up of the biggest news from Neuroscience 2017 here: https://www.neuro-central.com/2017/11/20/sfn17-news-highlights-speaker-interviews-neuroscience-2017/

Whilst at SfN's Neuroscience 2017, Lauren Pulling sat down with Kijun Yoon, who discussed the latest updates in Zika research, including his work on a Zika virus protein that may cause microcephaly.

Whilst at Society for Neuroscience's annual meeting (Washington DC, USA, 11–15 November 2017), Lauren Pulling (Editor) sat down with Doris Doudet (University of British Columbia, Canada) to hear more about her recent research, which has demonstrated elevated inflammation in the gut of a Parkinson's disease rat model.

This week we had the pleasure of attending ‘Clearing the brain: protein clearance in neurodegenerative disease’, a 1-day symposium organized by the Leonard Wolfson Experimental Neurology Centre (LWENC) at University College London (UCL; London, UK). The event saw researchers and clinicians from across the world come together to share the latest research and debate the future of the field, with topics spanning perivascular clearance, fluid biomarkers, glymphatics, lymphatics, and a lively panel discussion.

In this #NCTalks podcast, recorded at the event, we speak to Henrik Zetterberg, a Professor at the University of Gothenburg (Sweden) and UCL and one of the world’s leading experts in fluid biomarkers for neuronal injury and degeneration. In this podcast, he provides an update on the most promising blood-based biomarker candidates for neurodegenerative disease and tells us what he’s most excited to see in the coming years.

Want to find out more about the event? Catch up on our highlights on our Twitter (@Neuro_Central), plus stay tuned for video interviews with speakers John Hardy (UCL), Jonathan Kipnis (University of Virginia School of Medicine, VA, USA) and Jeffrey Iliff (Oregon Health and Science University, OR, USA) coming soon!

You can also find out more about the LWENC, dementia research at UCL and the event itself via the links below:

www.ucl.ac.uk/dementia

www.ucl.ac.uk/lwenc

www.justgiving.com/fundraising/ucldementiaseminars

Shalini Prasad and Sriram Muthukumar: non-invasive monitoring technologies by Taylor & Francis Group

Neuromodulatory techniques have risen in profile in recent years, with these groundbreaking therapies now being used to treat a vast range of conditions from Parkinson’s to pain, and obesity to depression. With these techniques now becoming more refined and more readily-available to patients, we spoke to Ali Rezai, a leading neurosurgeon and Director of The Ohio State University Neurological Institute (OH, USA). Dr Rezai has been involved in the pioneering use of brain pacemakers for treating Parkinson’s disease, depression, OCD and traumatic brain injury, and his current research focuses on developing neuromodulation therapies to treat migraine headaches, asthma, addictions, Alzheimer’s, obesity, post-traumatic stress disorders and autism.

Listen to our latest NCTalks podcast with Dr Rezai to hear more about his work, how neuromodulation can be harnessed to treat ‘alternative’ conditions, and where he hopes the field will progress in the next decade.

You can view more podcasts, plus the latest news and interviews with experts across neurology and neuroscience, at www.neuro-central.com.